BiomX Inc. Announces 1-for-19 Reverse Stock Split - BiomX (AMEX:PHGE)

Core Points - BiomX Inc. announced a one-for-nineteen reverse stock split of its common stock, effective November 25, 2025 [1][2][3] - The reverse stock split was approved by stockholders at the 2025 Annual Meeting on October 16, 2025, with the final ratio set by the Board of Directors on November 13, 2025 [2] - Following the reverse stock split, the number of outstanding shares will decrease from approximately 29,006,165 to about 1,526,640 [4] Company Overview - BiomX is a clinical-stage company focused on developing natural and engineered phage therapies to target specific pathogenic bacteria [5] - The company utilizes its BOLT platform to customize phage compositions aimed at treating chronic diseases with significant unmet medical needs [5]